𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The epidermal growth factor receptor as a target for gastrointestinal cancer therapy

✍ Scribed by Karen L. Tedesco; A. Craig Lockhart; Jordan D. Berlin

Publisher
Springer
Year
2004
Tongue
English
Weight
384 KB
Volume
5
Category
Article
ISSN
1527-2729

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-epidermal growth factor receptor-an
Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer
✍ Christine Solbach; Marc Roller; Andre Ahr; Sibylle Loibl; Maria Nicoletti; Manfr 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 118 KB 👁 1 views

Recent studies demonstrated that tumors overexpressing the epidermal growth factor receptor (EGF-R, erbB-1) are associated with poor clinical outcome. This led to the development of a variety of monoclonal antibodies targeting the extracellular domain of this receptor tyrosine kinase. The aim of our

Targeting the epidermal growth factor re
Targeting the epidermal growth factor receptor by erlotinib (Tarceva™) for the treatment of esophageal cancer
✍ Andreas P. Sutter; Michael Höpfner; Alexander Huether; Kerstin Maaser; Hans Sche 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 370 KB 👁 1 views

## Abstract Esophageal cancer is the sixth most common cause of cancer‐related death worldwide. Because of very poor 5‐year survival new therapeutic approaches are mandatory. Erlotinib (Tarceva™), an inhibitor of epidermal growth factor receptor tyrosine kinase (EGFR‐TK), potently suppresses the gr